Skip to main content
HUM
NYSE Finance

Humana Finalizes $1 Billion Junior Subordinated Notes Offering at 6.625%

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Healthcare
Sentiment info
Neutral
Importance info
8
Price
$180.932
Mkt Cap
$21.798B
52W Low
$169.614
52W High
$315.348
52W Position info
6.7% above low
Off High info
43% below high
Rel. Volume info
0.9× avg
Market data snapshot near publication time

HUM is trading near its 52-week low of $169.614 (6.7% above the low).

Summary

Humana Inc. has finalized the terms for its $1 billion offering of 6.625% fixed-to-fixed rate junior subordinated notes due 2056, with proceeds intended for general corporate purposes including debt repayment.


Key Events · Financing and Capital Events · HUM

  • Offering Finalized

    Humana Inc. finalized the terms of its $1 billion offering of 6.625% Fixed-to-Fixed Rate Junior Subordinated Notes due 2056. This follows the preliminary prospectus supplement filed earlier today.

  • Key Terms Set

    The notes bear an initial interest rate of 6.625% until September 15, 2031, after which the rate will reset. The issue price is 100% of the principal amount, with an expected settlement date of March 9, 2026.

  • Use of Proceeds

    The net proceeds will be used for general corporate purposes, which may include the repayment of existing indebtedness, such as borrowings under the company's commercial paper program.

  • Subordination and Flexibility

    The notes are junior subordinated to senior indebtedness, and Humana retains the option to defer interest payments for up to 10 consecutive years, providing financial flexibility.


Analysis · HUM · Finance

This Free Writing Prospectus finalizes the terms of a significant $1 billion debt offering, providing Humana with substantial capital. The proceeds are earmarked for general corporate purposes, including debt repayment, which can strengthen the company's balance sheet and liquidity position. The junior subordinated nature of the notes and the company's option to defer interest payments offer financial flexibility, though they also reflect the specific risk profile for investors in these notes. This capital raise is a material event for Humana's financial strategy, ensuring funding for operational needs and debt management.

At the time of this filing, HUM was trading at $180.93 on NYSE in the Finance sector, with a market capitalization of approximately $21.8B. The 52-week trading range was $169.61 to $315.35. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

HUM - Latest Insights

HUM
Jul 29, 2026, 6:00 AM EDT
Source: BusinessWire
Importance Score:
8
Price at Filing: $372.00
Real-time Price: $354.00 info
Change: -$18.00 (-5%) info
Market Cap: $46.669B info
HUM
Jun 17, 2026, 9:18 AM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $369.49
Real-time Price: $354.00 info
Change: -$15.49 (-4%) info
Market Cap: $46.669B info
HUM
Jun 01, 2026, 7:09 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $301.20
Real-time Price: $354.00 info
Change: +$52.80 (+18%) info
Market Cap: $46.669B info
HUM
May 19, 2026, 4:30 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $310.18
Real-time Price: $354.00 info
Change: +$43.82 (+14%) info
Market Cap: $46.669B info
HUM
Apr 29, 2026, 2:09 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $237.87
Real-time Price: $354.00 info
Change: +$116.13 (+49%) info
Market Cap: $46.669B info